A Study of PET/CT Scans With the Radioactive Tracer 89Zr-DFO-Daratumumab in People With Myeloma
Clinical trial NCT04467281 · WITHDRAWN
Trial details
- NCT number
- NCT04467281
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2021-02-26
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.